ID

40368

Description

Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy; ODM derived from: https://clinicaltrials.gov/show/NCT01782222

Lien

https://clinicaltrials.gov/show/NCT01782222

Mots-clés

Versions (1)
  1. 14/04/2020 14/04/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

14 avril 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Idiopathic Parkinson's Disease NCT01782222

Anglais

Eligibility Idiopathic Parkinson's Disease NCT01782222

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with early or advanced idiopathic parkinson's disease
Description

Parkinson Disease Early | Parkinson Disease Advanced

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C1279919
UMLS CUI [2,1]
C0030567
UMLS CUI [2,2]
C0205179
patients with advanced idiopathic parkinson's disease: intake of levodopa on a stable dose of at least 200 mg/day
Description

Parkinson Disease Advanced | Levodopa Dose Stable U/day

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C0205179
UMLS CUI [2,1]
C0023570
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [2,4]
C0456683
unsatisfactory control of parkinson's disease motor symptoms under current treatment
Description

Control Unsatisfactory Parkinson Disease | Motor symptoms Treating

Type de données

boolean

Alias
UMLS CUI [1,1]
C2587213
UMLS CUI [1,2]
C0439856
UMLS CUI [1,3]
C0030567
UMLS CUI [2,1]
C0426980
UMLS CUI [2,2]
C1522326
patients experiencing apathy associated with parkinson's disease
Description

Apathy Associated with Parkinson Disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0085632
UMLS CUI [1,2]
C0332281
UMLS CUI [1,3]
C0030567
hoehn and yahr stage score of i to iv
Description

Hoehn and Yahr Stage

Type de données

boolean

Alias
UMLS CUI [1]
C3639483
mini-mental state examination score ≥ 25
Description

Mini-mental state examination

Type de données

boolean

Alias
UMLS CUI [1]
C0451306
if an antidepressant drug is taken, the dose must be stable
Description

Antidepressive Agents Dose Stable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003289
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
therapy with a dopamine agonist
Description

Dopamine Agonists

Type de données

boolean

Alias
UMLS CUI [1]
C0178601
discontinuation from pervious therapy with a dopamine agonist after an adequate length of treatment, at adequate dose, due to lack of efficacy
Description

Dopamine Agonists Discontinued | Etiology Lack of Efficacy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0178601
UMLS CUI [1,2]
C1444662
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0235828
any medical or psychiatric condition that jeopardizes / compromises patient's ability for participation
Description

Medical condition At risk Study Subject Participation Status | Mental condition At risk Study Subject Participation Status | Medical condition Impairing Study Subject Participation Status | Mental condition Impairing Study Subject Participation Status

Type de données

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C1444641
UMLS CUI [1,3]
C2348568
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C1444641
UMLS CUI [2,3]
C2348568
UMLS CUI [3,1]
C3843040
UMLS CUI [3,2]
C0221099
UMLS CUI [3,3]
C2348568
UMLS CUI [4,1]
C3840291
UMLS CUI [4,2]
C0221099
UMLS CUI [4,3]
C2348568
patient has received neuroleptics, dopamine releasing substances, dopamine modulating substances, alpha-methyldopa, metoclopramide, mao-a inhibitors, budipine, or tolcapone
Description

Antipsychotic Agents | Substance Releasing Dopamine | Substance Modulating Dopamine | Methyldopa | Metoclopramide | Monoamine Oxidase Inhibitors | budipine | tolcapone

Type de données

boolean

Alias
UMLS CUI [1]
C0040615
UMLS CUI [2,1]
C0439861
UMLS CUI [2,2]
C1283071
UMLS CUI [2,3]
C0013030
UMLS CUI [3,1]
C0439861
UMLS CUI [3,2]
C0443264
UMLS CUI [3,3]
C0013030
UMLS CUI [4]
C0025741
UMLS CUI [5]
C0025853
UMLS CUI [6]
C0026457
UMLS CUI [7]
C0054202
UMLS CUI [8]
C0246330
electroconvulsive therapy
Description

Electroconvulsive Therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0013806
patient has a
Description

Patient has

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C3539897
current/anticipated psychotherapy or behavior therapy
Description

Psychotherapy | Behavior Therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0033968
UMLS CUI [2]
C0004933
history of deep brain stimulation
Description

Deep Brain Stimulation

Type de données

boolean

Alias
UMLS CUI [1]
C0394162
history of suicide attempt or has suicidal ideation
Description

History of suicide attempt | Feeling suicidal

Type de données

boolean

Alias
UMLS CUI [1]
C0455507
UMLS CUI [2]
C0424000
impulse control disorder
Description

Impulse control disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0868740
severe depression
Description

Severe depression

Type de données

boolean

Alias
UMLS CUI [1]
C0588008
Retour au début de la page

Similar models

Eligibility Idiopathic Parkinson's Disease NCT01782222

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Parkinson Disease Early | Parkinson Disease Advanced
Item
patients with early or advanced idiopathic parkinson's disease
boolean
C0030567 (UMLS CUI [1,1])
C1279919 (UMLS CUI [1,2])
C0030567 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
Parkinson Disease Advanced | Levodopa Dose Stable U/day
Item
patients with advanced idiopathic parkinson's disease: intake of levodopa on a stable dose of at least 200 mg/day
boolean
C0030567 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0023570 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0456683 (UMLS CUI [2,4])
Control Unsatisfactory Parkinson Disease | Motor symptoms Treating
Item
unsatisfactory control of parkinson's disease motor symptoms under current treatment
boolean
C2587213 (UMLS CUI [1,1])
C0439856 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,3])
C0426980 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
Apathy Associated with Parkinson Disease
Item
patients experiencing apathy associated with parkinson's disease
boolean
C0085632 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0030567 (UMLS CUI [1,3])
Hoehn and Yahr Stage
Item
hoehn and yahr stage score of i to iv
boolean
C3639483 (UMLS CUI [1])
Mini-mental state examination
Item
mini-mental state examination score ≥ 25
boolean
C0451306 (UMLS CUI [1])
Antidepressive Agents Dose Stable
Item
if an antidepressant drug is taken, the dose must be stable
boolean
C0003289 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Dopamine Agonists
Item
therapy with a dopamine agonist
boolean
C0178601 (UMLS CUI [1])
Dopamine Agonists Discontinued | Etiology Lack of Efficacy
Item
discontinuation from pervious therapy with a dopamine agonist after an adequate length of treatment, at adequate dose, due to lack of efficacy
boolean
C0178601 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0015127 (UMLS CUI [2,1])
C0235828 (UMLS CUI [2,2])
Medical condition At risk Study Subject Participation Status | Mental condition At risk Study Subject Participation Status | Medical condition Impairing Study Subject Participation Status | Mental condition Impairing Study Subject Participation Status
Item
any medical or psychiatric condition that jeopardizes / compromises patient's ability for participation
boolean
C3843040 (UMLS CUI [1,1])
C1444641 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C1444641 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C3843040 (UMLS CUI [3,1])
C0221099 (UMLS CUI [3,2])
C2348568 (UMLS CUI [3,3])
C3840291 (UMLS CUI [4,1])
C0221099 (UMLS CUI [4,2])
C2348568 (UMLS CUI [4,3])
Antipsychotic Agents | Substance Releasing Dopamine | Substance Modulating Dopamine | Methyldopa | Metoclopramide | Monoamine Oxidase Inhibitors | budipine | tolcapone
Item
patient has received neuroleptics, dopamine releasing substances, dopamine modulating substances, alpha-methyldopa, metoclopramide, mao-a inhibitors, budipine, or tolcapone
boolean
C0040615 (UMLS CUI [1])
C0439861 (UMLS CUI [2,1])
C1283071 (UMLS CUI [2,2])
C0013030 (UMLS CUI [2,3])
C0439861 (UMLS CUI [3,1])
C0443264 (UMLS CUI [3,2])
C0013030 (UMLS CUI [3,3])
C0025741 (UMLS CUI [4])
C0025853 (UMLS CUI [5])
C0026457 (UMLS CUI [6])
C0054202 (UMLS CUI [7])
C0246330 (UMLS CUI [8])
Electroconvulsive Therapy
Item
electroconvulsive therapy
boolean
C0013806 (UMLS CUI [1])
Patient has
Item
patient has a
boolean
C0030705 (UMLS CUI [1,1])
C3539897 (UMLS CUI [1,2])
Psychotherapy | Behavior Therapy
Item
current/anticipated psychotherapy or behavior therapy
boolean
C0033968 (UMLS CUI [1])
C0004933 (UMLS CUI [2])
Deep Brain Stimulation
Item
history of deep brain stimulation
boolean
C0394162 (UMLS CUI [1])
History of suicide attempt | Feeling suicidal
Item
history of suicide attempt or has suicidal ideation
boolean
C0455507 (UMLS CUI [1])
C0424000 (UMLS CUI [2])
Impulse control disorder
Item
impulse control disorder
boolean
C0868740 (UMLS CUI [1])
Severe depression
Item
severe depression
boolean
C0588008 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial